{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:20:11Z","timestamp":1794360011863,"version":"4.9.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["13CRP16860078"],"award-info":[{"award-number":["13CRP16860078"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["U54GM104938"],"award-info":[{"award-number":["U54GM104938"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s10840-016-0192-8","type":"journal-article","created":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T07:32:46Z","timestamp":1475307166000},"page":"51-60","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Intermittent vs. Continuous Anticoagulation theRapy in patiEnts with Atrial Fibrillation (iCARE-AF): a randomized pilot study"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4370-8135","authenticated-orcid":false,"given":"Stavros","family":"Stavrakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Stoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Kardokus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Garabelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny S.","family":"Po","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Lazzara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,1]]},"reference":[{"issue":"10","key":"192_CR1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","volume":"98","author":"EJ Benjamin","year":"1998","unstructured":"Benjamin EJ, Wolf PA, D\u2019Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98(10):946\u201352.","journal-title":"Circulation"},{"issue":"18","key":"192_CR2","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370\u20135.","journal-title":"JAMA"},{"issue":"21","key":"192_CR3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"CT January","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland Jr JC, et al. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1\u201376.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"192_CR4","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013;369(22):2093\u2013104.","journal-title":"N Engl J Med"},{"issue":"12","key":"192_CR5","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139\u201351.","journal-title":"N Engl J Med"},{"issue":"11","key":"192_CR6","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981\u201392.","journal-title":"N Engl J Med"},{"issue":"10","key":"192_CR7","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365(10):883\u201391.","journal-title":"N Engl J Med"},{"issue":"9921","key":"192_CR8","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955\u201362.","journal-title":"Lancet"},{"issue":"5","key":"192_CR9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.dld.2015.01.159","volume":"47","author":"L Loffredo","year":"2015","unstructured":"Loffredo L, Perri L, Violi F. Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: a meta-analysis of interventional trials. Dig Liver Dis. 2015;47(5):429\u201331.","journal-title":"Dig Liver Dis"},{"issue":"3","key":"192_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1160\/TH13-05-0424","volume":"111","author":"S Lahaye","year":"2014","unstructured":"Lahaye S, Regpala S, Lacombe S, Sharma M, Gibbens S, Ball D, et al. Evaluation of patients\u2019 attitudes towards stroke prevention and bleeding risk in atrial fibrillation. Thromb Haemost. 2014;111(3):465\u201373.","journal-title":"Thromb Haemost"},{"issue":"4","key":"192_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1161\/CIRCULATIONAHA.115.016795","volume":"132","author":"JJ Goldberger","year":"2015","unstructured":"Goldberger JJ, Arora R, Green D, Greenland P, Lee DC, Lloyd-Jones DM, et al. Evaluating the atrial myopathy underlying atrial fibrillation: identifying the arrhythmogenic and thrombogenic substrate. Circulation. 2015;132(4):278\u201391.","journal-title":"Circulation"},{"issue":"31","key":"192_CR12","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1093\/eurheartj\/eht135","volume":"34","author":"SM Al-Khatib","year":"2013","unstructured":"Al-Khatib SM, Thomas L, Wallentin L, Lopes RD, Gersh B, Garcia D, et al. Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. Eur Heart J. 2013;34(31):2464\u201371.","journal-title":"Eur Heart J"},{"issue":"20","key":"192_CR13","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","volume":"37","author":"AN Ganesan","year":"2016","unstructured":"Ganesan AN, Chew DP, Hartshorne T, Selvanayagam JB, Aylward PE, Sanders P, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J. 2016;37(20):1591\u2013602.","journal-title":"Eur Heart J"},{"issue":"5","key":"192_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","volume":"36","author":"BA Steinberg","year":"2015","unstructured":"Steinberg BA, Hellkamp AS, Lokhnygina Y, Patel MR, Breithardt G, Hankey GJ, et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial. Eur Heart J. 2015;36(5):288\u201396.","journal-title":"Eur Heart J"},{"issue":"12","key":"192_CR15","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1161\/STROKEAHA.115.010947","volume":"46","author":"K Takabayashi","year":"2015","unstructured":"Takabayashi K, Hamatani Y, Yamashita Y, Takagi D, Unoki T, Ishii M, et al. Incidence of stroke or systemic embolism in paroxysmal versus sustained atrial fibrillation: the Fushimi Atrial Fibrillation Registry. Stroke. 2015;46(12):3354\u201361.","journal-title":"Stroke"},{"issue":"7","key":"192_CR16","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/j.hrthm.2016.03.005","volume":"13","author":"P Sanders","year":"2016","unstructured":"Sanders P, Purerfellner H, Pokushalov E, Sarkar S, Di Bacco M, Maus B, et al. Performance of a new atrial fibrillation detection algorithm in a miniaturized insertable cardiac monitor: results from the Reveal LINQ Usability Study. Heart Rhythm. 2016;13(7):1425\u201330.","journal-title":"Heart Rhythm"},{"key":"192_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijcard.2015.04.241","volume":"191","author":"S Gunda","year":"2015","unstructured":"Gunda S, Reddy YM, Pillarisetti J, Koripalli S, Jeffery C, Swope J, et al. Initial real world experience with a novel insertable (Reveal LinQ(@Medtronic)) compared to the conventional (Reveal XT(@Medtronic)) implantable loop recorder at a tertiary care center\u2014points to ponder! Int J Cardiol. 2015;191:58\u201363.","journal-title":"Int J Cardiol"},{"issue":"6","key":"192_CR18","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1160\/TH14-03-0231","volume":"111","author":"N Lowres","year":"2014","unstructured":"Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014;111(6):1167\u201376.","journal-title":"Thromb Haemost"},{"issue":"23","key":"192_CR19","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1161\/01.CIR.99.23.3024","volume":"99","author":"EG Daoud","year":"1999","unstructured":"Daoud EG, Marcovitz P, Knight BP, Goyal R, Man KC, Strickberger SA, et al. Short-term effect of atrial fibrillation on atrial contractile function in humans. Circulation. 1999;99(23):3024\u20137.","journal-title":"Circulation"},{"issue":"7","key":"192_CR20","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/0735-1097(94)90652-1","volume":"23","author":"WJ Manning","year":"1994","unstructured":"Manning WJ, Silverman DI, Katz SE, Riley MF, Come PC, Doherty RM, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol. 1994;23(7):1535\u201340.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"192_CR21","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1016\/S0735-1097(03)00496-0","volume":"41","author":"M Takami","year":"2003","unstructured":"Takami M, Suzuki M, Sugi K, Ikeda T. Time course for resolution of left atrial appendage stunning after catheter ablation of chronic atrial flutter. J Am Coll Cardiol. 2003;41(12):2207\u201311.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"192_CR22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18(6):695\u2013706.","journal-title":"Stat Med"},{"issue":"1","key":"192_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","volume":"10","author":"R Simon","year":"1989","unstructured":"Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials. 1989;10(1):1\u201310.","journal-title":"Control Clin Trials"},{"issue":"9","key":"192_CR24","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/pace.12389","volume":"37","author":"EI Charitos","year":"2014","unstructured":"Charitos EI, Ziegler PD, Stierle U, Robinson DR, Graf B, Sievers HH, et al. Atrial fibrillation burden estimates derived from intermittent rhythm monitoring are unreliable estimates of the true atrial fibrillation burden. Pacing Clin Electrophysiol. 2014;37(9):1210\u20138.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"3","key":"192_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/jce.12864","volume":"27","author":"R Passman","year":"2016","unstructured":"Passman R, Leong-Sit P, Andrei AC, Huskin A, Tomson TT, Bernstein R, et al. Targeted anticoagulation for atrial fibrillation guided by continuous rhythm assessment with an insertable cardiac monitor: the Rhythm Evaluation for Anticoagulation with Continuous Monitoring (REACT.COM) Pilot Study. J Cardiovasc Electrophysiol. 2016;27(3):264\u201370.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"8","key":"192_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","volume":"35","author":"G Boriani","year":"2014","unstructured":"Boriani G, Glotzer TV, Santini M, West TM, De Melis M, Sepsi M, et al. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J. 2014;35(8):508\u201316.","journal-title":"Eur Heart J"},{"issue":"10","key":"192_CR27","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.jacc.2005.07.044","volume":"46","author":"A Capucci","year":"2005","unstructured":"Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G, et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol. 2005;46(10):1913\u201320.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"192_CR28","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","volume":"2","author":"TV Glotzer","year":"2009","unstructured":"Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol. 2009;2(5):474\u201380.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"192_CR29","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120\u20139.","journal-title":"N Engl J Med"},{"issue":"21","key":"192_CR30","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","volume":"129","author":"M Brambatti","year":"2014","unstructured":"Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C, et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014;129(21):2094\u20139.","journal-title":"Circulation"},{"issue":"9","key":"192_CR31","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.hrthm.2011.04.022","volume":"8","author":"EG Daoud","year":"2011","unstructured":"Daoud EG, Glotzer TV, Wyse DG, Ezekowitz MD, Hilker C, Koehler J, et al. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm. 2011;8(9):1416\u201323.","journal-title":"Heart Rhythm"},{"issue":"8","key":"192_CR32","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jacc.2012.11.046","volume":"61","author":"HS Lim","year":"2013","unstructured":"Lim HS, Willoughby SR, Schultz C, Gan C, Alasady M, Lau DH, et al. Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. J Am Coll Cardiol. 2013;61(8):852\u201360.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"192_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1540-8175.2003.03011.x","volume":"20","author":"JA Larsen","year":"2003","unstructured":"Larsen JA, McPherson DD, Kadish AH, Goldberger JJ. Course of intraatrial thrombi resolution using transesophageal echocardiography. Echocardiography. 2003;20(2):121\u20138.","journal-title":"Echocardiography"},{"issue":"6","key":"192_CR34","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/CIRCEP.114.001356","volume":"7","author":"P Zimetbaum","year":"2014","unstructured":"Zimetbaum P, Waks JW, Ellis ER, Glotzer TV, Passman RS. Role of atrial fibrillation burden in assessing thromboembolic risk. Circ Arrhythm Electrophysiol. 2014;7(6):1223\u20139.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"192_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1540-8167.2008.01320.x","volume":"20","author":"GL Botto","year":"2009","unstructured":"Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F, et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol. 2009;20(3):241\u20138.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"3","key":"192_CR36","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1468-1331.2011.03547.x","volume":"19","author":"MJ Cha","year":"2012","unstructured":"Cha MJ, Kim YD, Nam HS, Kim J, Lee DH, Heo JH. Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2-VASc scores. Eur J Neurol. 2012;19(3):473\u20139.","journal-title":"Eur J Neurol"},{"issue":"20","key":"192_CR37","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1093\/eurheartj\/ehw014","volume":"37","author":"JA Reiffel","year":"2016","unstructured":"Reiffel JA. If it were only that simple. Eur Heart J. 2016;37(20):1603\u20135.","journal-title":"Eur Heart J"},{"issue":"11","key":"192_CR38","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/S0735-1097(03)00426-1","volume":"41","author":"MA Lee","year":"2003","unstructured":"Lee MA, Weachter R, Pollak S, Kremers MS, Naik AM, Silverman R, et al. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol. 2003;41(11):1926\u201332.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"192_CR39","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1540-8159.2009.02181.x","volume":"32","author":"G Quirino","year":"2009","unstructured":"Quirino G, Giammaria M, Corbucci G, Pistelli P, Turri E, Mazza A, et al. Diagnosis of paroxysmal atrial fibrillation in patients with implanted pacemakers: relationship to symptoms and other variables. Pacing Clin Electrophysiol. 2009;32(1):91\u20138.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"26","key":"192_CR40","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","volume":"36","author":"DT Martin","year":"2015","unstructured":"Martin DT, Bersohn MM, Waldo AL, Wathen MS, Choucair WK, Lip GY, et al. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J. 2015;36(26):1660\u20138.","journal-title":"Eur Heart J"},{"issue":"8","key":"192_CR41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s12325-012-0040-x","volume":"29","author":"F Laliberte","year":"2012","unstructured":"Laliberte F, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, Duh MS. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients. Adv Ther. 2012;29(8):675\u201390.","journal-title":"Adv Ther"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-016-0192-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-016-0192-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-016-0192-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T10:29:04Z","timestamp":1589711344000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-016-0192-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["192"],"URL":"https:\/\/doi.org\/10.1007\/s10840-016-0192-8","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,1]]},"assertion":[{"value":"8 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}